NDC 44118-704-01 - Vytone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 44118-704
- Requested NDC
- 44118-704-01
- Package NDCs from labels
- 44118-704-01, 44118-704-30
- Manufacturer
- Eckson Labs LLC
- Effective date
- 2024-11-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Vytone - Eckson Labs LLC | Eckson Labs LLC | 2024-11-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 44118-704-01 | Vytone | 2 g in 1 PACKET | CREAM | 2 | 2 | |
| 44118-704-30 | Vytone | 30 in 1 CARTON | CREAM | 30 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 44118-704-01 | GM - Gram | 44118-704 | 36400332-a486-4161-8f84-1eedbebc604a | 1 | 2022-05-04 |
| 44118-704-30 | GM - Gram | 44118-704 | 317049b9-cf2c-4bed-ae2f-cba9f24a6ac9 | 1 | 2022-05-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrocortisone Acetate Pramoxine Hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Bryant Ranch Prepack | 79fae74b-bef2-4e13-a2e9-da68747951eb | 2023-07-18 | Adverse reactions | 3X7931PO74 |
| hydrocortisone acetate pramoxine HCl | HYDROCORTISONE ACETATE, PRAMOXINE HCL | Bryant Ranch Prepack | 2c74c1c8-91c7-4468-9b1a-721783431196 | 2023-07-18 | Adverse reactions | 3X7931PO74 |
| hydrocortisone acetate pramoxine HCl | HYDROCORTISONE ACETATE, PRAMOXINE HCL | Bryant Ranch Prepack | 1436a6cb-5fa1-41a6-87af-dfbaf0ab2e5b | 2023-07-18 | Adverse reactions | 3X7931PO74 |
| hydrocortisone acetate pramoxine hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Bryant Ranch Prepack | 3c5e1833-9908-4e4f-bdf2-7a28c14a585c | 2023-07-18 | Adverse reactions | 3X7931PO74 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | QUAGEN PHARMACEUTICALS LLC | 60dce400-1138-4781-b621-1774c0dbb64a | 2023-05-17 | Adverse reactions | 3X7931PO74 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | A-S Medication Solutions | 03321951-e338-4955-8622-0f5ea29c6cd9 | 2023-01-18 | Adverse reactions | 3X7931PO74 |
| Radiaura Skin Recovery | LIDOCAINE HCL - HYDROCORTISONE ACETATE | PureTek Corporation | c9502692-674d-e53f-e053-2a95a90a74b3 | 2023-01-11 | Warnings, Adverse reactions | 3X7931PO74 |
| hydrocortisone acetate pramoxine HCl | HYDROCORTISONE ACETATE, PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 982f0862-2be8-4a65-8b61-8f3a95ab5951 | 2022-05-31 | Adverse reactions | 3X7931PO74 |
| Hydrocortisone Acetate Pramoxine Hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 87a4c494-56f9-48f6-8592-d610c507a4fc | 2022-05-31 | Adverse reactions | 3X7931PO74 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | Padagis US LLC | 2fdb9940-6da8-49b0-a236-9817943f7a4b | 2022-05-31 | Adverse reactions | 3X7931PO74 |
| hydrocortisone acetate pramoxine hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 9eea5875-d153-4bba-aee2-b1d1cd8b5e57 | 2022-05-31 | Adverse reactions | 3X7931PO74 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | APNAR PHARMA LP | cb60f2a6-8bab-c0f9-e053-2a95a90a422a | 2022-03-16 | Adverse reactions | 3X7931PO74 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | Patrin Pharma Inc. | 7c1d2c8c-26e2-432f-b983-505f259665a9 | 2021-12-22 | Adverse reactions | 3X7931PO74 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | Proficient Rx LP | 43ed7a9a-0aaf-4987-8367-e2490d1b8448 | 2020-05-07 | Adverse reactions | 3X7931PO74 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.